Perthera Report Pancreatic Version Now Available, Revolutionizing Chemo Selection for Pancreatic Cancer Treatment
First-of-Its-Kind AI Predictor Eliminates Guesswork in Frontline Chemotherapy Selection, Empowering Oncologists with Unprecedented Data-Driven Insights MCCLEAN, VA, UNITED STATES, February 26, 2025 /EINPresswire.com/ — Perthera, The Therapeutic Intelligence Company, today announced the launch of the Perthera Report® Pancreatic version (PRPv)—a …
Read more »